Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Letrozole 2.5mg
You Searched
Letroher 2.5mg Tablet
₹190
Our Recommendation
Fempro 2.5mg Tablet 10s
2,938+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Breast cancer Letroher 2.5mg Tablet relieves the symptoms of breast cancer such as breast lumps, bloody discharge from the nipple, or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on cancer to stop its growth. In Treatment of Infertility due to anovulation Letroher 2.5mg Tablet helps in the normal development of an egg in a woman's ovary (female reproductive organ) and stimulates the release of the egg during a process called ovulation. This helps to treat infertility in women. This increases the chance of a successful pregnancy. You should use the medicine as prescribed for it to be effective.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Letroher 2.5mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
Letroher 2.5mg Tablet is an aromatase inhibitor. It works by decreasing the amount of estrogen (natural female hormone) produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow. In addition, it is also useful in infertility whereby it increases the release of certain hormones to stimulate the release of eggs from the ovaries.
Safe: No harmful side effects are associated with consuming alcohol alongside Letroher 2.5mg Tablet
Not Safe: Letroher 2.5mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Not Safe: Letroher 2.5mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Letroher 2.5mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Letroher 2.5mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Letroher 2.5mg Tablet is recommended. However, there is limited information on the use of this medicine in patients with end stage kidney disease. Please consult with your doctor.
Caution Advised: Letroher 2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Letroher 2.5mg Tablet may be needed. Doctor consultation is advised.
If a dose of Letroher 2.5mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
128, HPSIDC . Inds. Area , baddi -173205(H.P)
Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1762
Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 786-87
Letrozole. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 1997 (03 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (04 Apr. 2019)
National Health Service. Letrozole (08 Jul. 2023)
Letrozole (08 Jul. 2023)
Letrozole (08 Jul. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.